Showing 641 - 660 results of 104,186 for search '(( 50 we decrease ) OR ( 5 ((((step decrease) OR (teer decrease))) OR (a decrease)) ))', query time: 1.30s Refine Results
  1. 641

    Liquid–Liquid Phase Separation of Peptide/Oligonucleotide Complexes in Crowded Macromolecular Media by Qingwen Bai (5221280)

    Published 2020
    “…Our study provides a further step toward a deeper understanding of the kinetics of MLOs in crowded living cells.…”
  2. 642

    Liquid–Liquid Phase Separation of Peptide/Oligonucleotide Complexes in Crowded Macromolecular Media by Qingwen Bai (5221280)

    Published 2020
    “…Our study provides a further step toward a deeper understanding of the kinetics of MLOs in crowded living cells.…”
  3. 643
  4. 644
  5. 645
  6. 646
  7. 647

    rVλ6Wil fibrils cause oxidative stress in cardiomyocytes without a decrease in cellular ATP. by Helen P. McWilliams-Koeppen (116503)

    Published 2015
    “…<p>(A) After a 2 h incubation with rVλ6Wil fibrils or monomer, cellular ATP levels, as detected by luminescence (black bars), were not significantly reduced relative to the PBS-treated control. …”
  8. 648
  9. 649
  10. 650
  11. 651
  12. 652
  13. 653

    A long-term "memory" of HIF induction in response to chronic mild decreased oxygen after oxygen normalization-5 by Chandrashekhar D Kamat (60176)

    Published 2011
    “…<p><b>Copyright information:</b></p><p>Taken from "A long-term "memory" of HIF induction in response to chronic mild decreased oxygen after oxygen normalization"</p><p>BMC Cardiovascular Disorders 2007;7():4-4.…”
  14. 654
  15. 655

    Inhibition of IL-17A at tumor sites decreases the intratumoral microvessel density. by Keiji Hayata (277090)

    Published 2013
    “…<p>(A) The endothelial maker CD31-stained sections of tumor tissue are shown in Ad-SNC and Ad-si-IL-17 treatment models, Ad-si-IL-17 treatment decreased the intratumoral microvessel density compared with Ad-SNC. …”
  16. 656
  17. 657
  18. 658

    S1 Dataset - by Nelmo Jordão Manjate (16324619)

    Published 2023
    “…We conducted a retrospective cost analysis from the provider’s perspective using a bottom-up, micro-costing approach, and compared the direct costs of two nasopharyngeal Ag-RDTs (Panbio and Standard Q) against the costs of three nasal Ag-RDTs (Panbio, COVIOS and LumiraDx), and RT-PCR. …”
  19. 659
  20. 660